# AIVD Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aivd-biotech

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.aivdbiotech.cn
- Total disclosed funding: $15M
- Latest round: Series A (Jun 25, 2021)
- Investors on record: 2

## About

Established in 2014 and based in Shenzhen, China, AIVD Biotech Inc. is a biotechnology company that focuses on providing in-vitro diagnostic reagent products. The company has established a diagnostic reagent raw material research and development center, an immunodiagnostic reagent research and development center and a molecular diagnostic reagent research and development center for antibody, antigen and reagent research and development. It has also built a screening program for generating truly specific, single chain monoclonal antibody fragments (also known as Nanobodies) that can be used in immunodiagnostic assay development. 

The company's products include reagent raw materials, neutralization antibody detection kits, COVID-19 diagnosis products & reagents, etc.

## Funding rounds

- Series A, Jun 25, 2021, $15M — Shenzhen HTI, Nanling Fund

## Investors

- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Series A
- Nanling Fund — Series A